4//SEC Filing
MEDNAX, INC. 4
Accession 0001209191-17-010046
$MDCIK 0000893949operating
Filed
Feb 12, 7:00 PM ET
Accepted
Feb 13, 4:50 PM ET
Size
19.6 KB
Accession
0001209191-17-010046
Insider Transaction Report
Form 4
Goldschmidt Pascal J
Director
Transactions
- Exercise/Conversion
Common Stock
2017-02-10$32.33/sh+818$26,442→ 14,173 total - Exercise/Conversion
Common Stock
2017-02-10$27.71/sh+10,668$295,664→ 24,841 total - Exercise/Conversion
Common Stock
2017-02-10$29.36/sh+9,922$291,260→ 34,763 total - Exercise/Conversion
Common Stock
2017-02-10$36.25/sh+8,280$300,150→ 43,043 total - Sale
Common Stock
2017-02-10$67.82/sh−25,294$1,715,318→ 17,749 total - Exercise/Conversion
Stock Options (Right to Buy)
2017-02-10$32.33/sh−818$26,442→ 0 totalExercise: $32.33From: 2010-11-01Exp: 2017-11-01→ Common Stock (818 underlying) - Exercise/Conversion
Stock Options (Right to Buy)
2017-02-10$27.71/sh−10,668$295,664→ 0 totalExercise: $27.71From: 2011-05-23Exp: 2018-05-23→ Common Stock (10,668 underlying) - Exercise/Conversion
Stock Options (Right to Buy)
2017-02-10$29.36/sh−9,922$291,260→ 0 totalExercise: $29.36From: 2013-05-06Exp: 2020-05-06→ Common Stock (9,922 underlying) - Exercise/Conversion
Stock Options (Right to Buy)
2017-02-10$36.25/sh−8,280$300,150→ 0 totalExercise: $36.25From: 2014-05-05Exp: 2021-05-05→ Common Stock (8,280 underlying)
Footnotes (1)
- [F1]Sales of shares were made in thirty-three (33) separate transactions with prices ranging from $67.70 to $68.05 for an average weighted sales price of $67.8152.
Documents
Issuer
MEDNAX, INC.
CIK 0000893949
Entity typeoperating
IncorporatedFL
Related Parties
1- filerCIK 0000893949
Filing Metadata
- Form type
- 4
- Filed
- Feb 12, 7:00 PM ET
- Accepted
- Feb 13, 4:50 PM ET
- Size
- 19.6 KB